Detalhe da pesquisa
1.
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
Clin Infect Dis
; 70(1): 1-10, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125055
2.
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.
N Engl J Med
; 376(4): 330-341, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830322
3.
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.
Vaccine
; 40(12): 1864-1871, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35153091
4.
Bullous erythema multiforme after treatment with Malarone, a combination antimalarial composed of atovaquone and proguanil hydrochloride.
Trop Doct
; 38(3): 190-1, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18628561
5.
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.
PLoS One
; 4(3): e4708, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19262754
6.
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
PLoS One
; 4(7): e6465, 2009 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19649245
7.
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.
PLoS Clin Trials
; 1(7): e32, 2006 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-17124529